ID: MRFR/Pharma/3341-HCR | 110 Pages | Author: Rahul Gotadki | October 2023
Figure 1 Global Sciatica Market by Drug Treatment, 2016 (%)
Segments
The global sciatica market has been segmented on the basis of types, drug treatment, devices and end user.
Based on the types, the sciatica market has been segmented as L4 nerve root sciatica, L5 nerve root sciatica, S1 nerve root sciatica and others.
Based on the drugs, the market has been segmented as anesthetics, pain killers, muscle relaxants, antidepressants, steroids and others.
Based on the non-drug treatment, the market has been segmented as physiotherapy, acupuncture, stimulation devices, surgery and others.
Based on the end user, the market has been segmented as hospitals and clinics, research and academics and others.
Regional Analysis
The Americas accounts for a significant sciatica market share owing to high expenditure on the healthcare especially of the U.S. and Canada. Additionally, greater number of orthopedic procedures due to greater healthcare penetration in the U.S. and Canada drives the sciatica market. The high concentration of the major hospitals in the developed countries of this region coupled with good reimbursement rates is adding fuel to the market growth. Moreover, the large share of surgical procedures especially the sciatica treatment in the returns of hospitals favors the market. A large number of medical devices companies in the U.S. is also a cause for the faster development of sciatica market in the US.
Europe is the second largest market in the world due to the growing medical devices industry and healthcare penetration. The European market growth is led by countries such as Germany and France. Germany is expected to be the fastest growing market over the assessment period due to its large medical devices industry.
Asia Pacific region is expected to grow rapidly where China and India are likely to lead the market due to faster growing healthcare sector and larger unmet needs over the forecast period. The South East Asian countries such as China, India, and Malaysia are projected to contribute highly to the market growth. The growing penetration of healthcare industry in the Asia Pacific region is expected to drive the future sciatica market in the region.
Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. Other Middle Eastern nations to watch out for are Kuwait, Jordan, Egypt and Iran. The African region is expected to witness a poor growth owing to poor economic and political conditions, and poor healthcare development. Other regions are expected to be laggards due to poor social development and tribal identities such as sub Saharan Africa.
Key Players in the Global Sciatica Market
Some of the key players profiled in the report are Endo Pharmaceuticals, AstraZeneca, Novartis AG, Teva Pharmaceutical Industries, Neurotech, Nidd Valley Medical, Omega Laser Systems Ltd., Omron Healthcare, Inc., Sanofi and others.
Research Methodology
Sources: Mayo Clinic, Healthline Media, MRFR Analysis
Intended Audience
Sciatica market size is projected to expand at 9.9% CAGR from 2022-2030.
Sciatica market valuation can touch USD 19,399 Million by 2030.
Sciatica market is driven by the large elderly populace and intense screening procedures for detection of nerve pain.
High costs of sciatica treatment and adverse effects of its drugs can stunt the global sciatica market growth.
Neurotech, Novartis AG, AstraZeneca, Sanofi, Endo Pharmaceuticals, Omega Laser Systems Ltd., Teva Pharmaceutical Industries, Omron Healthcare, Inc., and Nidd Valley Medical are key players of the global sciatica market.
Key Questions Answered
Why Choose Market Research Future?